Additionally, transgenic mice used as a model of AD disease were shown to have reduced BRCA1 levels, an important DNA repair factor, which was accompanied by an increase in DSB and synaptic impairments, among other symptoms associated to AD (Suberbielle et al., 2015). Here, BRCA1 is linked to Alzheimer disease.